CD33 is a protein expressed in 85–90% of AML blasts and LSCs, as well as in normal myelopoiesis, specifically in early multilineage hematopoietic progenitor and more mature myeloid cells, but not in stem cells or multipotent progenitor cells [30]. Here, CD33 is linked to acute myeloid leukemia.